In Brief: FDA pharmacoeconomics conference
FDA pharmacoeconomics conference: "Comparing Treatments: Safety, Effectiveness, and Cost-Effectiveness" will explore "methodological and regulatory principles that should be used to guide research design, review and communications when direct comparisons are made between active drug/biological treatments." Topics for the March 23-24 meeting include: "What type of information is needed in the managed care/payor communities?" and "How is the pharmaceutical industry responding to these new demands?" The conference will be held at NIH's Masur Auditorium. To register and get a preliminary program call (301) 594-6812 or fax (301) 594-6759...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth